Font size: Normal | Large | X-Large
 

Clinical Trials

Treatment of retinal diseases is a rapidly changing field of medicine with new techniques and procedures being developed every year. Southwest Retina Specialists has been involved with research over the last six years for a variety of retina conditions, including Diabetic Macular Edema, Vitreous Hemorrhage with surgical intervention, and Age-Related Macular Degeneration.

While clinical trials are always voluntary, to qualify a patient would go through a screening process to determine eligibility that varies from study to study.

Please contact our study coordinator, Kasey Dalrymple, at 806-351-1870 (ext. 1113) if you are interested in being screened or want more information on a clinical trial being conducted.

You can learn more about each trial and how to participate in a clinical trial at:
http://www.ClinicalTrials.gov
http://www.fda.gov

Current Studies Open for Enrollment:

WET MACULAR DEGENERATION (Actively Recruiting)

Outlook Therapeutics ONS-5010-002
A Clinical Effectiveness, Multicenter, Randomized, Double-masked, Controlled Study of the Efficacy and Safety of ONS-5010 in Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration

  • ClinicalTrials.gov Identifier: NCT03844074
  • Sponsor: Outlook Therapeutics, Inc.
  • Site: Southwest Retina Specialist, Amarillo, TX.

 

DRY MACULAR DEGENERATION (Active Investigation)

Apellis 303 Derby
A Phase III, Multi-Center, Randomized, Double-Masked, Sham Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

  • ClinicalTrials.gov Identifier: NCT03525600
  • Sponsor: Apellis Pharmaceuticals, Inc.
  • Site: Southwest Retina Specialist, Amarillo, TX